脂蛋白相关磷脂酶A2及其与冠心病相关性的研究进展
被引量:2
出处
《检验医学》
CAS
北大核心
2010年第9期740-743,共4页
Laboratory Medicine
作者简介
作者简介:马明坤,女,1979年生,学士,主管技师,主要从事免疫学和微生物学工作。
参考文献16
-
1Lerman A,McConnell JP.Lipoprotein-associated pho-spholipase A2:a risk marker or a risk factor[J].Am J Cardiol,2008,101(12A):11F-22F.
-
2刘建辉,张春妮.脂蛋白相关磷脂酶A2与动脉粥样硬化的关系[J].中国动脉硬化杂志,2008,16(7):569-571. 被引量:14
-
3张鹭,张浩.磷脂酶A2及其功能概述[J].齐齐哈尔医学院学报,2004,25(2):178-180. 被引量:15
-
4Zalewski A,Nelson JJ,Hegg L,et al.LP-PLA2:a new kid on the block[J].Clin Chem,2006,52(9):1645-1650.
-
5Brilakis ES,Khera A,McGuire DK,et al.Influence of race and sex on lipoprotein-associated phospholipase A2 levels:observations from the Dallas heart study[J].Atherosclerosis,2008,199(1):110-115.
-
6M(o)ckel M,Müller R,Vollert JO,et al.Lipoprotein-associated phospholipase A2 for early risk stratification in patients with suspected acute coronary syndrome:a multi-marker approach:the north Wuerttemberg and Berlin infarction study-Ⅱ (NOBIS-Ⅱ)[J].Clin Res Cardiol,2007,96(9):604-612.
-
7O′Donoghue M,Morrow DA,Sabatine MS,et al.Lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction) trial[J].Circulation,2006,113(14):1745-1752.
-
8Vickers KC,Maguire CT,Wolfert R,et al.Rela-tionship of lipoprotein-associated phospholipase A2 and oxidized low density lipoprotein in carotid atherosclerosis[J].J Lipid Res,2009,50(9):1735-1743.
-
9刘军妮,徐冬玲,杜贻萌,姚桂华,蒋卫东,赵敬杰,董兆强,隋树建,王欣,鹿庆华.血清脂蛋白相关磷脂酶A_2与冠状动脉粥样硬化斑块稳定性的相关研究——附107例报告[J].新医学,2009,40(1):18-20. 被引量:18
-
10Raichlin E,McConnell JP,Bae JH,et al.Lipoprotein-associated phospholipase A2 predicts progression of cardiac allograft vasculopathy and increased risk of cardiovascular events in heart transplant patients[J].Transplantation,2008,85(7):963-968.
二级参考文献60
-
1梁茜,董吁钢,杨希立,杨光,崔金环.血管紧张素转换酶、内皮型一氧化氮合酶和载脂蛋白E基因多态性与冠心病的相关性[J].中山大学学报(医学科学版),2006,27(4):396-400. 被引量:7
-
2刘松.-[J].国外医学:呼吸系统分册,1997,17(3):128-130.
-
3CORSETTI J P, RAINWATER D L, MOSS A J, et al. High lipoprotein-associated phospholipase A2 is a risk factor for recurrent coronary events in postinfarction patients [J]. ClinChem, 2006, 52 (7): 1331-1338.
-
4BRILAKIS E S, MCCONNELL J P, LENNON R J, et al. Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up[J]. Eur Heart J, 2005, 26 (2) : 137-144.
-
5陶文惠 黄文增.冠状动脉粥样硬化性心脏病30例的血清胆红素检测分析.新医学,1999,30(6):332-332.
-
6NAGHAVI M, LIBBY P, FALK E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part Ⅰ [ J ]. Circulation, 2003, 108 (14) : 1664-1672.
-
7MINTZ G S, NISSEN S E, ANDERSON W D, et al. American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (ivus). A report of the american college of cardiology task force on clinical expert consensus documents developed in collaboration with the european society of cardiology endorsed by the society of cardiac angiography and interventions [ J ]. J Am Coll Cardiol, 2001, 37 (5) : 1478-1492.
-
8DE KORTE C L, SIEREVOGEL M J, MASTIK F, et al. Identification of atherosclerotic plaque components with intravascular ultrasound elastography in vivo: a Yucatan pig study[J]. Circulation, 2002, 105(14): 1627-1630.
-
9BALLANTYNE C M, HOOGEVEEN R C, BANG H, et al. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study [ J ]. Circulation, 2004, 109 (7): 837-842.
-
10Keiji Tabuchi,Zenya Ito,Shigeki Tsuji,Tetsuro Wada,Kazuhiko Takahashi,Akira Hara,Tetsuro Wada,KazuhikoTakahashi,Akira Hara,Jun Kusakari. The contribution of phospholipase A2 to the cochlear dysfunction induced by transient ischemia[J]. Hearing Research,20
共引文献44
-
1李彩云,胡丽杰,韩飞,刘强.血浆脂蛋白相关磷脂酶A2与缺血性脑卒中的相关性研究[J].名医,2019,0(11):80-80.
-
2刘强,曾慧,杨灿,陈克岩,陈恩伟,韩飞.Lp-PLA2与D-D联合检测对缺血性脑卒中的诊断及神经功能损伤的影响[J].解剖学研究,2020(5):389-392. 被引量:4
-
3李娜,高晓刚.脂蛋白相关性磷脂酶A2与缺血性心脑血管疾病风险预测的研究进展[J].中国动脉硬化杂志,2008,16(12):1005-1008. 被引量:4
-
4张艳,梁标.磷脂酶A_2的调节机制[J].吉林医学,2005,26(12):1374-1376. 被引量:4
-
5马安德,吴少瑜,张嘉杰,李志琴,徐伟,文晓芸,余乐,吴曙光.一种新的蝮蛇蛇毒磷脂酶A2同源物的分离纯化及其对Hep3B细胞基因谱的影响[J].南方医科大学学报,2006,26(1):75-79. 被引量:2
-
6马安德,吴少瑜,张嘉杰,李志琴,徐伟,余乐,文晓芸,吴曙光.一种新的蝮蛇蛇毒磷脂酶A2同源物的分离纯化及其氨基酸序列分析[J].中药材,2006,29(2):132-134. 被引量:3
-
7敖平星,翁银标,高洪.自由基在二恶英毒性机理中的作用及其清除剂的保护效应研究[J].中国畜牧兽医,2006,33(12):82-85. 被引量:2
-
8马长玲,胡旭初,胡凤玉,李艳文,赵俊红,郑小凌,余新炳.华支睾吸虫磷脂酶A_2基因生物学特性的初步研究[J].中国病原生物学杂志,2009,4(10):767-770.
-
9张湘瑜,屈晓冰,彭孝立.老年人脂蛋白相关磷脂酶A2与冠心病冠状动脉病变程度及危险因素的关系[J].中华老年医学杂志,2009,28(11):901-904. 被引量:5
-
10李园,陈苏宁.超声检测颈动脉粥样硬化斑块与冠心病的相关性研究[J].上海医学影像,2009,18(4):330-332. 被引量:17
同被引文献26
-
1姚祖培,陈建新,陶玉华.化瘀复元胶囊治疗脑动脉硬化症36例的临床观察[J].中西医结合心脑血管病杂志,2005,3(11):951-952. 被引量:1
-
2柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2165
-
3Ross R. Atherosclerosis: an inflammatory disease [ J]. N Engl J Med,1999,340(2) :115 -126.
-
4Armstrong EJ,Morrow DA,Sabatine MS. Inflammatory biomarkers in a-cute coronary syndromes : part II : acute - phase reactants and biomark-ers ofendothelial cell activation. Circulation ,2006,113(8) : 152 -155.
-
5Li JJ,Fang CH. C - reactive protein is not only an inflammatory maker-but also a direct cause of cardiovascular diseases. Medicalhypotheses,2004,62:499-506.
-
6Ishikawa T,Imamura T,Hatakeyama K,Date H,Nagoshi T, KawamotoR,Matsuyama A,Asada Y,Eto T. Possible contribution of C - reactive-protein within coronary plaque to increasing its own plasma ievelsacrosscoronary circulation. The American Journal of cardiology,2004,93 :611-614.
-
7Oei HH, van der Meer IM, Hofman A,et al. Lipoprotein - associated-phospholipase A2 activity is associated with risk of coronary heartdis-ease and ischemic stroke : the Rotterdam Study. Circulation,2005,111:570 -575.
-
8Corson MA,Jones PH, Davidson MH. Review of the evidence for the-Clinical utility of lipoprotein - associated phospholipase A2 as acardio-vascular risk marker. Am J Cardiol,2008,101 :41F -51F.
-
9Garza CA, Montori VM, McConnell JP,et al. Association betweenLi-poprotein associated phosphorlipase A2 and cardiovasculardisease : asystematic review. Mayo Clin Proceedings ,2007 ,82 : 159 - 165.
-
10周端,童存存,褛丹飞.冠心病辨治经验[J].2011年中华中医药学会心病分会学术年会暨北京中医药学会心血管病专业委员会年会,2011:102-104.
二级引证文献9
-
1陈磊,刘新灿,孙天福,朱翠玲,李明.急性冠脉综合症患者通心络干预后脂蛋白相关磷脂酶A2变化[J].中国实用医药,2013,8(19):131-132. 被引量:1
-
2黄少兴,李雪华,邱双成.脂蛋白磷脂酶A2检测在心脑血管疾病中的诊断价值[J].赣南医学院学报,2015,35(2):287-288. 被引量:4
-
3任峰.血液Lp-PLA_2、hs-CRP与D-二聚体检验在急性冠状动脉综合征患者中的应用研究[J].中国医药指南,2015,13(22):42-44.
-
4蔡文花,李丽敏,王雪敏,孙翠清,赵海伟,王辉,刘瑞超,韦素春.不同高血压合并症患者炎症指标的变化[J].中国医药指南,2015,13(30):20-21.
-
5庞雅君,曾蕾,李华友.膜性肾病并发血栓的危险因素[J].中国实用医药,2015,10(36):84-85. 被引量:3
-
6杨艳.高血压合并冠心病患者心功能与D-二聚体检验水平的相关研究[J].中外医疗,2016,35(13):61-62. 被引量:2
-
7玉洪新,刘杰.冠心病病人血液Lp-PLA_2、hs-CRP及D-二聚体的相关性研究[J].中西医结合心脑血管病杂志,2016,14(12):1405-1407. 被引量:14
-
8彭金祥,姚祖培.化瘀复元胶囊治疗冠状动脉微血管病变心绞痛临床观察[J].云南中医中药杂志,2019,40(10):32-34. 被引量:5
-
9卞维仕.冠心病患者心功能与D-二聚体检验水平的相关研究[J].中外医疗,2015,34(30):186-187.
-
1杲修杰,刘晓华,钱令嘉.脂蛋白相关磷脂酶A2表达载体的构建[J].长江大学学报(自科版)(中旬),2009,6(3):39-41.
-
2黄美容,黄健,王虹,徐绣宇,王鹏,尹一兵,胥文春.脂蛋白相关磷脂酶A2的原核表达及多克隆抗体的制备[J].中国生物制品学杂志,2011,24(4):460-463. 被引量:6
-
3陈曦,谌海兰,陈特,曾令斌,赵家宁,尹一兵,胥文春.重组人脂蛋白相关磷脂酶A2的原核表达及其纯化[J].中国生物制品学杂志,2013,26(10):1400-1404.
-
4于滢,杨向红.基质金属蛋白酶与动脉粥样硬化及斑块破裂的关系[J].中国动脉硬化杂志,2003,11(6):592-595. 被引量:38
-
5汪俊军.脂蛋白(a)相连的脂蛋白相关磷脂酶A_2在动脉粥样硬化中的作用[J].医学研究生学报,2009,22(8):785-788. 被引量:12
-
6赵颖,董天崴,李海涛,杨军.脂蛋白相关磷脂酶A2的研究进展[J].心血管康复医学杂志,2011,20(6):599-601. 被引量:14
-
7霍欣,陈眷华,徐在品,谭建民.与动脉粥样硬化相关细胞的研究进展[J].贵州畜牧兽医,2007,31(4):14-15.
-
8颜怀军,周越球,徐超.中国浙江汉族成年男性Apo C-1基因型与脂蛋白相关磷脂酶A2活性的关系[J].检验医学,2010,25(11):879-882. 被引量:5
-
9盛富强,徐蓉,党书毅,王俊峰,许海军.Acute myocardial infarction associated with coronary spasm in a young man[J].South China Journal of Cardiology,2011,12(2):136-138.
-
10汪晶,潘永明,徐孝平,蔡月琴,陈方明,蔡兆伟,陈民利.高脂诱导五指山小型猪动脉粥样硬化模型的建立及Lp-PLA_2的表达调控[J].中国实验动物学报,2017,25(2):194-200. 被引量:9